- Investing Ideas
- Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Selvita
Market Cap: zł580.0m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł31.00
7D
3.7%
1Y
2.6%
Ryvu Therapeutics
Market Cap: zł320.0m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł13.90
7D
-2.7%
1Y
-56.8%
Poltreg
Market Cap: zł112.4m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł18.95
7D
5.3%
1Y
-39.6%
Molecure
Market Cap: zł112.1m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.44
7D
-4.4%
1Y
1.1%